1,234
Views
4
CrossRef citations to date
0
Altmetric
Articles

Adherence to prophylaxis in adolescents and young adults with severe haemophilia A, a qualitative study with patients

, , &
Pages 277-300 | Received 25 Jan 2018, Accepted 22 Jun 2018, Published online: 24 Sep 2018

References

  • Ahlberg, Å. (1965). Haemophilia in Sweden VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthopaedica Scandinavica, 36(suppl. 77), 3–132. doi: 10.3109/ort.1965.36.suppl-77.01
  • Alvin, P., Rey, C., & Frappier, J. Y. (1995). Compliance thérapeutique chez l’adolescent malade chronique. Archives de Pédiatrie, 2(9), 874–882. doi: 10.1016/0929-693X(96)81267-X
  • Arias Llorente, R. P., Bousoño García, C., & Díaz Martín, J. J. (2008). Treatment compliance in children and adults with cystic fibrosis. Journal of Cystic Fibrosis, 7(5), 359–367. doi: 10.1016/j.jcf.2008.01.003
  • Ar Muhlis, C., Vaide, I., Berntorp, E., & Björkman, S. (2014). Methods for individualising factor VIII dosing in prophylaxis. European Journal of Haematology, 93(s76), 16–20. doi: 10.1111/ejh.12370
  • Bolton-Maggs, P. H. B., & Pasi, K. J. (2003). Haemophilias A and B. The Lancet, 361(9371), 1801–1809. Retrieved from http://linkinghub.elsevier.com/retrieve/pii/S0140673603134058 doi: 10.1016/S0140-6736(03)13405-8
  • Collins, P. W. (2012). Personalized prophylaxis. Haemophilia, 18(4), 131–135. doi: 10.1111/j.1365-2516.2012.02838.x
  • Collins, P. W., Blanchette, V. S., Fischer, K., BjÖRkman, S., Oh, M., Fritsch, S., … On Behalf Of The Rahf-Pfm Study, G. (2009). Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. Journal of Thrombosis and Haemostasis, 7(3), 413–420. doi: 10.1111/j.1538-7836.2008.03270.x
  • Coppola, A., Di Capua, M., & De Simone, C. (2008). Primary prophylaxis in children with haemophilia. Blood Transfusion, 6(2), s11–s11. doi: 10.2450/2008.0030-08
  • De Moerloose, P., Urbancik, W., Van Den Berg, H. M., & Richards, M. (2008). A survey of adherence to haemophilia therapy in six European countries: Results and recommendations. Haemophilia, 14(5), 931–938. doi: 10.1111/j.1365-2516.2008.01843.x
  • Den Uijl, I., Mauser Bunschoten, E., Roosendaal, G., Schutgens, R., Biesma, D., Grobbee, D., & Fischer, K. (2011). Clinical severity of haemophilia A: Does the classification of the 1950s still stand? Haemophilia, 17(6), 849–853. doi: 10.1111/j.1365-2516.2011.02539.x
  • DiMatteo, M. R. (2004). Variations in patients? Adherence to medical recommendations. Medical Care, 42(3), 200–209. doi: 10.1097/01.mlr.0000114908.90348.f9
  • Duncan, N., Kronenberger, W., Roberson, C., & Shapiro, A. (2010). VERITAS-Pro: A new measure of adherence to prophylactic regimens in haemophilia. Haemophilia, 16(2), 247–255. doi: 10.1111/j.1365-2516.2009.02129.x
  • du Treil, S., Rice, J., & Leissinger, C. A. (2007). Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia, 13(5), 493–501. doi: 10.1111/j.1365-2516.2007.01526.x
  • Farrugia, A., Gringeri, A., & von Mackensen, S. (2018). The multiple benefits of sport in haemophilia. Haemophilia, 24(3), 341–343. doi: 10.1111/hae.13496
  • Feeling angry? Frustrated? Anxious? Low? Haemophilia Society website. Retrieved from http://haemophilia.org.uk/support/day-day-living/patient-support/healthy-living/positive-mental-health/on 10-06-2018
  • Fischer, K. (2012). Prophylaxis for adults with haemophilia: One size does not fit all. Blood Transfusion, 10(2), 169–173. doi: 10.2450/2012.0174-11
  • Fischer, K., Astermark, J., van der Bom, J. G., Ljung, R., Berntop, E, Grobbee, D. E., & van den Berg, H. M. (2002). Prophylactic treatment for severe haemophilia: comparison of an intermediate‐dose to a high‐dose regimen. Haemophilia, 8, 753–760. doi: 10.1046/j.1365-2516.2002.00694.x
  • Gallant, M. P. (2003). The influence of social support on chronic illness self-management: A review and directions for research. Health Education & Behavior, 30(2), 170–195. doi: 10.1177/1090198102251030
  • Gringeri, A., Doralt, J., Valentino, L. A., Crea, R., & Reininger, A. J. (2016). An innovative outcome-based care and procurement model of hemophilia management. Expert Review of Pharmacoeconomics & Outcomes Research, 16(3), 337–345. doi: 10.1080/14737167.2016.1178066
  • Griva, K., Myers, L. B., & Newman, S. (2000). Illness perceptions and self efficacy beliefs in adolescents and young adults with insulin dependent diabetes mellitus. Psychology & Health, 15(6), 733–750. doi: 10.1080/08870440008405578
  • Hacker, M., Geraghty, S., & Manco-Johnson, M. (2001). Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia, 7(4), 392–396. doi: 10.1046/j.1365-2516.2001.00534.x
  • Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47(6), 555–567. doi: 10.1016/S0022-3999(99)00057-4
  • Howell, C., Scott, K., & Patel, D. R. (2017). Sports participation recommendations for patients with bleeding disorders. Translational Pediatrics, 6(3), 174–180. doi: 10.21037/tp.2017.04.07
  • Iannotti, R. J., Schneider, S., Nansel, T. R., Haynie, D. L., Plotnick, L. P., Clark, L. M., & Simons-Morton, B. (2006). Self-efficacy, outcome expectations, and diabetes self-management in adolescents with type 1 diabetes. Journal of Developmental and Behavioral Pediatrics, 27(2), 98–105. doi: 10.1097/00004703-200604000-00003
  • Khair, K. (2013). Supporting adherence and improving quality of life in haemophilia care. British Journal of Nursing, 22(12), 692. doi: 10.12968/bjon.2013.22.12.692
  • Khair, K., & Holland, M. (2013). Managing hemophilia: The role of mobile technology. Smart Homecare Technology and TeleHealth, 2, 39–44.
  • KyngÄs, H. A., Kroll, T., & Duffy, M. E. (2000). . Compliance in adolescents with chronic diseases: a review. Journal of Adolescent Health, 26(6), 379–388. doi: 10.1016/S1054-139X(99)00042-7
  • La Greca, A. M., & Bearman, K. J. (2002). The diabetes social support questionnaire-family version: Evaluating adolescents’ diabetes-specific support from family members. Journal of Pediatric Psychology, 27(8), 665–676. doi: 10.1093/jpepsy/27.8.665
  • La Greca, A. M., La Greca, A. M., Auslander, W. F., Auslander, W. F., Greco, P., Greco, P., & Santiago, J. V. (1995). I get by with a little help from my family and friends: Adolescents’ support for diabetes care. Journal of Pediatric Psychology, 20(4), 449–476. doi: 10.1093/jpepsy/20.4.449
  • Ljung, R. (2009). Prophylactic therapy in haemophilia. Blood Reviews, 23(6), 267–274. doi: 10.1016/j.blre.2009.08.001
  • Llewellyn, C. D., Miners, A. H., Lee, C. A., Harrington, C., & Weinman, J. (2003). The illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatment. Psychology & Health, 18(2), 185–200. doi: 10.1080/0887044031000098198
  • Makris, M. (2012). Prophylaxis in haemophilia should be life-long. Blood Transfusion, 10(2), 165–168. doi: 10.2450/2012.0147-11
  • Manco-Johnson, M. J., Abshire, T. C., Shapiro, A. D., Riske, B., Hacker, M. R., Kilcoyne, R., & Evatt, B. (2007). Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. New England Journal of Medicine, 357(6), 535–544. doi: 10.1056/NEJMoa067659
  • McQuaid, E. L., Kopel, S. J., Klein, R. B., & Fritz, G. K. (2003). Medication adherence in pediatric asthma: Reasoning, responsibility, and behavior. Journal of Pediatric Psychology, 28(5), 323–333. doi: 10.1093/jpepsy/jsg022
  • Miners, A. (2009). Revisiting the cost-effectiveness of primary prophylaxis with clotting factor for the treatment of severe haemophilia A. Haemophilia, 15(4), 881–887. doi: 10.1111/j.1365-2516.2009.02019.x
  • Nilsson, I. M. (1993). Experience with prophylaxis in Sweden. Seminars in Hematology, 30(3 Suppl. 2), 16–19.
  • Nilsson, I. M., Berntop, E., Lofqvist, T., & Pettersson, H. (1992). Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B. Journal of Internal Medicine, 232(1), 25–32. doi: 10.1111/j.1365-2796.1992.tb00546.x
  • Omura, K., Ito, M., Eguchi, E., Imahuku, K., Kutsumi, M., Inoue, Y., & Yamazaki, Y. (2013). The effect of peer support groups on self-care for haemophilic patients with HIV in japan. Haemophilia, 19(6), 876–881. doi: 10.1111/hae.12222
  • Ott, J., Greening, L., Palardy, N., Holderby, A., & DeBell, W. K. (2000). Self-Efficacy as a mediator variable for adolescents’ adherence to treatment for insulin-dependent diabetes mellitus. Children’s Health Care, 29(1), 47–63. doi: 10.1207/S15326888CHC2901_4
  • Panicker, J., Warrier, I., Thomas, R., & Lusher, J. (2003). The overall effectiveness of prophylaxis in severe haemophilia. Haemophilia, 9(3), 272–278. doi: 10.1046/j.1365-2516.2003.00757.x
  • Reid, K., Flowers, P., & Larkin, M. (2005). Exploring lived experience. The Psychologist, 18(1), 20–23.
  • Richards, M., Williams, M., Chalmers, E., Liesner, R., Collins, P., Vidler, V., … Paediatric Working Party of the United Kingdom Haemophilia Doctors, O. (2010). A United Kingdom haemophilia centre doctors’ organization guideline approved by the British committee for standards in haematology: Guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A. British Journal of Haematology, 149(4), 498–507. doi: 10.1111/j.1365-2141.2010.08139.x
  • Salema, N.-E. M., Elliott, R. A., & Glazebrook, C. (2011). A systematic review of adherence-enhancing interventions in adolescents taking long-term medicines. Journal of Adolescent Health, 49(5), 455–466. doi: 10.1016/j.jadohealth.2011.02.010
  • Schrijvers, L. H., Uitslager, N., Schuurmans, M. J., & Fischer, K. (2013). Barriers and motivators of adherence to prophylactic treatment in haemophilia: A systematic review. Haemophilia, 19(3), 355–361. doi: 10.1111/hae.12079
  • Shaw, R. J. (2001). Treatment adherence in adolescents: Development and psychopathology. Clinical Child Psychology and Psychiatry, 6(1), 137–150. doi: 10.1177/1359104501006001011
  • Smith, J. A. (2003). Qualitative psychology: A practical guide to research methods. London: Sage.
  • Smith, J. A. (2010). Interpretative phenomenological analysis: A reply to Amedeo Giorgi. Existential Analysis. Existential Analysis: Journal of the Society for Existential Analysis, 21(2), 186–192.
  • Smith, J., Flowers, P., & Larkin, M. (2009). Interpretative phenomenological analysis: Theory, method and research. Los Angeles. CA: Sage.
  • Smith, J. A., & Osborn, M. (2003). Interpretative phenomenological analysis. In J. A. Smith (Ed.), Qualitative psychology: A practical guide to research methods (pp. 53–80). London: Sage.
  • Thornburg, C. D. (2008). Physicians’ perceptions of adherence to prophylactic clotting factor infusions. Haemophilia, 14(1), 25–29. doi: 10.1111/j.1365-2516.2007.01591.x
  • van Os, S., Troop, N., Sullivan, K., & Hart, D. (2017). Adherence to prophylaxis in adolescents and young adults with severe haemophilia: A quantitative study with patients. PLoS One, 12(1), e0169880. doi: 10.1371/journal.pone.0169880
  • Witmer, C., Presley, R., Kulkarni, R., Michael Soucie, J., Manno, C. S., & Raffini, L. (2011). Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States. British Journal of Haematology, 152(2), 211–216. doi: 10.1111/j.1365-2141.2010.08469.x
  • Yardley, L. (2000). Dilemmas in qualitative health research. Psychology & Health, 15(2), 215–228. doi: 10.1080/08870440008400302
  • Yardley, L. (2008). Demonstrating validity in qualitative psychology. Qualitative Psychology: A Practical Guide to Research Methods, 2, 235–251.